Prostate Cancer Supplements BPH Prevention Treatment Options

The Prostate Doctor

ProstateDoctor.com is here to help you sort through some basics on prostate health. We also help choosing some supplements to support that health. With multitudes of nutritional products aimed at the consumer, sometimes making decision on how to spend your dollar wisely is difficult. This site will give you what we consider to be the best way to spend your dollar, as well as some education on what the products do.

More than 75% of prostate cancers are diagnosed in men 65 years or older.
African Americans have a higher incidence for prostate cancer, and are twice as likely to die from prostate cancer that white males. This is partially due to the fact that African Americans are more likely to be seen by a physician when the disease is more advanced.
A man with a 1st degree relative that has a history of prostate cancer, has 2-3 times more risk than the general population of developing prostate cancer. This risk increases to 6 times with a 1st and 2nd degree relative that have prostate cancer.
Over 170,000 cases of Prostate cancer diagnosed in 1999
Over 35,000 deaths from Prostate cancer in 1999
Can occur at any age, but most common over the age of 50.
Twice as common in African-American Men.
89% of those with diagnosed prostate cancer live longer than 5 years after diagnosis.
63% of those with diagnosed prostate cancer live longer than 10 years after diagnosis.
If found before it spreads outside the prostate gland, then survival approaches 100%.
If prostate cancer is found to have spread to the tissues surrounding the prostate gland, then survival is approximately 94%.
If prostate cancer has spread to areas distant to the prostate, then the survival rate is approx. 30% after 5 years.
There is an approximate 10% increase in your chances of getting prostate cancer if another male in you family has had it.
The older you are the greater your chance for prostate cancer.
High fat diet is believed to be associated with an increase in prostate cancer.

Highly recommended herbal product for those at risk

Zyflamend®

New Chapter Zyflamend

Studies:

1-Zyflamend, a unique herbal preparation with nonselective COX inhibitory activity, induces apoptosis of prostate cancer cells that lack COX-2 expression.1: Nutr Cancer. 2005;52(2):202-12

PubMed Ref #: 16201851

2-Inhibition of lipoxygenase activity: implications for the treatment and chemoprevention of prostate cancer.1: Cancer Biol Ther. 2007 Feb;6(2):237. Epub 2007 Feb 8.

PubMed: 17387265

3-The role of Zyflamend, an herbal anti-inflammatory, as a potential chemopreventive agent against prostate cancer: a case report.Integr Cancer Ther. 2007 Mar;6(1):74-6

PMID: 17351029 [PubMed - indexed for MEDLINE]

4-Zyflamend-mediated inhibition of human prostate cancer PC3 cell proliferation: effects on 12-LOX and Rb protein phosphorylation Cancer Biol Ther. 2007 Feb;6(2):228-36. Epub 2007 Feb 25

PMID: 17218785 [PubMed - indexed for MEDLINE]

* These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease. If you are pregnant or planning on getting pregnant in the near future always consult your primary care provider before starting any new supplements.

Disclaimer

The Vitamin Journal

MRIProstateCancerCenter.com

Clinical Centers of Excellence for Prostate Cancer Treatment

Cedars-Sinai Medical Center

Cleveland Clinic

Duke University Medical Center

Johns Hopkins

Loyola University

Mayo Clinic

Memorial Sloan-Kettering

University California San Francisco